Clinical trial Recruiting at 1 site Interventional Ages 55 to 90

Virtual reality-based cognitive and physical rehab for people with mild cognitive impairment or subjective cognitive decline

Official title: Feasibility, Usability, and Acceptability of Virtual Reality-Based Cognitive and Physical Rehabilitation in Individuals With Mild Cognitive Impairment (VR-MCI)

Run by The University of Texas Health Science Center, Houston · NCT07638748 · Data updated 2026-11-12

This study tests whether VR-based cognitive and physical rehabilitation is feasible, usable, and acceptable for people with mild cognitive impairment or subjective cognitive decline.

Quick facts

Study typeInterventional
Ages55 Years to 90 Years
SexAll
Enrollment10 (estimated)
SponsorThe University of Texas Health Science Center, Houston
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedJune 18, 2026
Main results expectedNovember 13, 2026
Study endsNovember 13, 2026
Registry record updatedSeptember 2, 2026
Trial IDNCT07638748 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with a clinical diagnosis of MCI (MoCA 18–26) or those with self-reported subjective cognitive decline who can provide informed consent, speak English, and attend sessions.

Probably not a fit

Individuals who experience significant contraindications to VR, cannot tolerate VR, or have conditions that interfere with participation may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project is a feasibility study to see if virtual reality–driven cognitive and physical rehabilitation can be implemented in this population. It will measure how well participants can use the VR sessions, how often they adhere to the program, and how tolerable the experience is. The study will also explore preliminary effects on cognitive, physical, and daily functional outcomes. No efficacy claims are made until data support is gathered.

Why it matters

Potential benefit: If successful, VR rehabilitation could become a convenient option to help maintain or improve cognitive and physical function in this group.

How similar studies have gone: Previous approaches using VR for cognitive and/or physical rehab have shown feasibility in related populations, but this specific combination in MCI/SCD is still being explored.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinical diagnosis of MCI (MoCA 18-26) or self-reported subjective cognitive decline (SCD)
* Capacity to provide informed consent
* Able to provide own transportation to sessions
* Speaks and understands English
* Ambulatory

Exclusion Criteria:

* Uncontrolled seizures or epilepsy
* Severe psychiatric illness or active suicidality
* Inability to follow instructions or tolerate VR (severe motion sickness)
* Cognitive impairment as a result of a known cause (e.g., dementia, stroke, Traumatic Brain Injury (TBI), medications, etc.)
* Any condition that the research team determines would interfere with safe participation

Where it's running

  • The University of Texas Health Science Center at Houston
    Houston, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Seema Aggarwal, PhD, APRN, AGNP-C — The University of Texas Health Science Center, Houston
  • Study coordinator: Seema S Aggarwal, PhD, APRN, AGNP-C
  • Email: Seema.S.Aggarwal@uth.tmc.edu
  • Phone: (713) 500-9946

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.